Bodhi Tree Biotechnology reported a net margin of -231.94% for the quarter ended Jun 2026. These financial ratios cover 5 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2024 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBT Margin | -1,295.54% | -89.06% | -231.95% | ||
| EBIT Margin | -1,295.54% | -89.06% | -231.95% | ||
| EBITDA Margin | -1,295.54% | -89.06% | -231.95% | ||
| Operating Margin | -1,295.54% | -89.06% | -231.95% | ||
| Net Margin | -1,295.54% | -89.06% | -231.94% | ||
| FCF Margin | -1,305.54% | -84.27% | |||
| Efficiency | |||||
| Assets AverageAssets Avg. | 140,235.00 | 124,504.50 | 94,437.00 | 44,018.00 | |
| Asset Utilization RatioAsset Util. | 0.14 | 0.13 | 0.50 | ||
| Return Ratios | |||||
| Return on Sales [ROS]ROS | -1,295.54% | -89.06% | -1,131.58% | -231.95% | |
| Return on Capital Employed [ROCE]ROCE | -149.32% | -270.27% | |||
| Return on Assets [ROA]ROA | -120.21% | -145.96% | -244.46% |